The Effect of Enoxaparin Sodium (Clexane) on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Incidence of deep vein thrombosis
研究概览
简要总结
The purpose of this study is to assess the effect of the anticoagulant(blood thinner) Clexane on the development of leg clots following electrophysiology studies (EPS) and or radiofrequency ablation (RFA).
People who suffer heart palpitations will sometimes need hospital admission to undergo an electrophysiology study ( and or a Radiofrequency Ablation)in order to diagnose and or treat their condition.
Radiofrequency ablation is a procedure to stop abnormal heart rhythms. EPS/RFA studies require the puncture of the leg veins . Previous experience has shown that following the puncture of leg veins there is a small risk of developing a blood clot in the leg.
It is not known whether giving blood thinners (anticoagulants) after the procedure will decrease this risk Enoxaparin Sodium (Clexane) is an anticoagulant used extensively and safely following bone (Orthopaedic) surgery to prevent blood clots from developing in the legs
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients undergoing EPS/RFA for the diagnosis and or treatment of SVT based on patient history or ECG evidence.
排除标准
- •Patients with a past history of DVT or PE.
- •Patients with a history of clotting disorders
- •Patients with active malignancies
- •Patients requiring full heparinisation during and after the procedure.
- •Chronic atrial flutter and atrial fibrillation ablation
研究组 & 干预措施
clexane
patients received clexane
干预措施: Clexane (Drug)
结局指标
主要结局
Incidence of deep vein thrombosis
时间窗: 1 year
次要结局
未报告次要终点